Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Sep;60(3):315–319. doi: 10.1038/bjc.1989.277

An immunotoxin containing momordin suitable for bone marrow purging in multiple myeloma patients.

A Dinota 1, L Barbieri 1, M Gobbi 1, P L Tazzari 1, S Rizzi 1, A Bontadini 1, A Bolognesi 1, S Tura 1, F Stirpe 1
PMCID: PMC2247190  PMID: 2789938

Abstract

Attempts have been made by a number of methods to eliminate minimal residual disease from bone marrow to be reinfused in autologous transplantation. In this paper we describe a conjugate containing a monoclonal antibody, named 8A, recognising a plasma cell-associated antigen, and momordin, a ribosome-inactivating protein similar to the ricin A-chain. This immunotoxin is active on target cell lines and on neoplastic plasma cells, while myeloid progenitors are fairly resistant. The conjugate is shown to be acceptable for ex vivo purging in autologous bone marrow transplantation in multiple myeloma patients.

Full text

PDF
315

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbieri L., Dinota A., Gobbi M., Tazzari P. L., Rizzi S., Bontadini A., Lemoli R. M., Tura S., Stirpe F. Immunotoxins containing saporin 6 and monoclonal antibodies recognizing plasma cell-associated antigens: effects on target cells and on normal myeloid precursors (CFU-GM). Eur J Haematol. 1989 Mar;42(3):238–245. doi: 10.1111/j.1600-0609.1989.tb00105.x. [DOI] [PubMed] [Google Scholar]
  2. Barlogie B., Alexanian R., Dicke K. A., Zagars G., Spitzer G., Jagannath S., Horwitz L. High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma. Blood. 1987 Sep;70(3):869–872. [PubMed] [Google Scholar]
  3. Barlogie B., Hall R., Zander A., Dicke K., Alexanian R. High-dose melphalan with autologous bone marrow transplantation for multiple myeloma. Blood. 1986 May;67(5):1298–1301. [PubMed] [Google Scholar]
  4. Bontadini A., Gobbi M., Dinota A., Tazzari P. L., Rivano M. T., Pileri S. In situ immunocytochemical staining of cell colonies growing in plasma clot. Histochemistry. 1988;89(3):237–240. doi: 10.1007/BF00493146. [DOI] [PubMed] [Google Scholar]
  5. Colombatti M., Bron C. Sensitivity of target cells to immunotoxins: possible role of cell-surface antigens. Immunology. 1985 Jun;55(2):331–338. [PMC free article] [PubMed] [Google Scholar]
  6. Dicke K. A., Spitzer G. Evaluation of the use of high-dose cytoreduction with autologous marrow rescue in various malignancies. Transplantation. 1986 Jan;41(1):4–20. doi: 10.1097/00007890-198601000-00002. [DOI] [PubMed] [Google Scholar]
  7. Endo Y., Mitsui K., Motizuki M., Tsurugi K. The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins. J Biol Chem. 1987 Apr 25;262(12):5908–5912. [PubMed] [Google Scholar]
  8. Goldmacher V. S., Anderson J., Blättler W. A., Lambert J. M., Senter P. D. Antibody-complement-mediated cytotoxicity is enhanced by ribosome-inactivating proteins. J Immunol. 1985 Dec;135(6):3648–3651. [PubMed] [Google Scholar]
  9. Hale G., Swirsky D., Waldmann H., Chan L. C. Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation. Br J Haematol. 1985 May;60(1):41–48. doi: 10.1111/j.1365-2141.1985.tb07383.x. [DOI] [PubMed] [Google Scholar]
  10. Iscove N. N., Senn J. S., Till J. E., McCulloch E. A. Colony formation by normal and leukemic human marrow cells in culture: effect of conditioned medium from human leukocytes. Blood. 1971 Jan;37(1):1–5. [PubMed] [Google Scholar]
  11. Jiménez A., Vázquez D. Plant and fungal protein and glycoprotein toxins inhibiting eukaryote protein synthesis. Annu Rev Microbiol. 1985;39:649–672. doi: 10.1146/annurev.mi.39.100185.003245. [DOI] [PubMed] [Google Scholar]
  12. Lemoli R. M., Gobbi M., Tazzari P. L., Tassi T. C., Dinota A., Visani G., Grassi G., Mazza P., Cavo M., Tura S. Bone marrow purging for multiple myeloma by avidin-biotin immunoadsorption. Transplantation. 1989 Feb;47(2):385–387. doi: 10.1097/00007890-198902000-00040. [DOI] [PubMed] [Google Scholar]
  13. Lokhorst H. M., Boom S. E., Bast B. J., Peters P. J., Tedder T. F., Gerdes J., Petersen E., Ballieux R. E. Novel type of proliferating lymphoplasmacytoid cell with a characteristic spotted immunofluorescence pattern. J Clin Invest. 1987 May;79(5):1401–1411. doi: 10.1172/JCI112968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Prentice H. G., Blacklock H. A., Janossy G., Bradstock K. F., Skeggs D., Goldstein G., Hoffbrand A. V. Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia. Lancet. 1982 Mar 27;1(8274):700–703. doi: 10.1016/s0140-6736(82)92619-8. [DOI] [PubMed] [Google Scholar]
  15. Ramakrishnan S., Houston L. L. Inhibition of human acute lymphoblastic leukemia cells by immunotoxins: potentiation by chloroquine. Science. 1984 Jan 6;223(4631):58–61. doi: 10.1126/science.6318313. [DOI] [PubMed] [Google Scholar]
  16. Roberts W. K., Selitrennikoff C. P. Plant proteins that inactivate foreign ribosomes. Biosci Rep. 1986 Jan;6(1):19–29. doi: 10.1007/BF01145175. [DOI] [PubMed] [Google Scholar]
  17. Stirpe F., Barbieri L. Ribosome-inactivating proteins up to date. FEBS Lett. 1986 Jan 20;195(1-2):1–8. doi: 10.1016/0014-5793(86)80118-1. [DOI] [PubMed] [Google Scholar]
  18. Stirpe F., Derenzini M., Barbieri L., Farabegoli F., Brown A. N., Knowles P. P., Thorpe P. E. Hepatotoxicity of immunotoxins made with saporin, a ribosome-inactivating protein from Saponaria officinalis. Virchows Arch B Cell Pathol Incl Mol Pathol. 1987;53(5):259–271. doi: 10.1007/BF02890252. [DOI] [PubMed] [Google Scholar]
  19. Stirpe F., Wawrzynczak E. J., Brown A. N., Knyba R. E., Watson G. J., Barbieri L., Thorpe P. E. Selective cytotoxic activity of immunotoxins composed of a monoclonal anti-Thy 1.1 antibody and the ribosome-inactivating proteins bryodin and momordin. Br J Cancer. 1988 Nov;58(5):558–561. doi: 10.1038/bjc.1988.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Tazzari P. L., Gobbi M., Dinota A., Bontadini A., Grassi G., Cerato C., Cavo M., Pileri S., Caligaris-Cappio F., Tura S. Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodies. Clin Exp Immunol. 1987 Oct;70(1):192–200. [PMC free article] [PubMed] [Google Scholar]
  21. Thorpe P. E., Brown A. N., Bremner J. A., Jr, Foxwell B. M., Stirpe F. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo. J Natl Cancer Inst. 1985 Jul;75(1):151–159. [PubMed] [Google Scholar]
  22. Tura S., Cavo M., Baccarani M., Ricci P., Gobbi M. Bone marrow transplantation in multiple myeloma. Scand J Haematol. 1986 Feb;36(2):176–179. doi: 10.1111/j.1600-0609.1986.tb00824.x. [DOI] [PubMed] [Google Scholar]
  23. Uckun F. M., Ramakrishnan S., Houston L. L. Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow. J Immunol. 1985 Mar;134(3):2010–2016. [PubMed] [Google Scholar]
  24. Vitetta E. S., Uhr J. W. Immunotoxins. Annu Rev Immunol. 1985;3:197–212. doi: 10.1146/annurev.iy.03.040185.001213. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES